vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and CVR PARTNERS, LP (UAN). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $180.0M, roughly 1.5× CVR PARTNERS, LP). CVR PARTNERS, LP runs the higher net margin — 27.7% vs 1.4%, a 26.4% gap on every dollar of revenue. On growth, CVR PARTNERS, LP posted the faster year-over-year revenue change (26.0% vs 9.7%). Over the past eight quarters, CVR PARTNERS, LP's revenue compounded faster (16.4% CAGR vs 5.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
CVR Partners, LP is a leading North American producer of nitrogen-based fertilizer products, primarily urea ammonium nitrate (UAN) and ammonia. It serves agricultural, industrial and commercial markets across the U.S. and Canada, delivering cost-effective, high-quality nutrient solutions for crop production and diverse industrial use cases.
ACAD vs UAN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $180.0M |
| Net Profit | $3.6M | $49.9M |
| Gross Margin | — | 37.5% |
| Operating Margin | -1.7% | 32.0% |
| Net Margin | 1.4% | 27.7% |
| Revenue YoY | 9.7% | 26.0% |
| Net Profit YoY | — | 84.3% |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $180.0M | ||
| Q4 25 | $284.0M | $131.1M | ||
| Q3 25 | $278.6M | $163.5M | ||
| Q2 25 | $264.6M | $168.6M | ||
| Q1 25 | $244.3M | $142.9M | ||
| Q4 24 | $259.6M | $139.6M | ||
| Q3 24 | $250.4M | $125.2M | ||
| Q2 24 | $242.0M | $132.9M |
| Q1 26 | $3.6M | $49.9M | ||
| Q4 25 | $273.6M | $-10.3M | ||
| Q3 25 | $71.8M | $43.1M | ||
| Q2 25 | $26.7M | $38.8M | ||
| Q1 25 | $19.0M | $27.1M | ||
| Q4 24 | $143.7M | $18.3M | ||
| Q3 24 | $32.8M | $3.8M | ||
| Q2 24 | $33.4M | $26.2M |
| Q1 26 | — | 37.5% | ||
| Q4 25 | 90.8% | 4.4% | ||
| Q3 25 | 92.2% | 37.0% | ||
| Q2 25 | 92.2% | 32.4% | ||
| Q1 25 | 91.7% | 29.7% | ||
| Q4 24 | 91.6% | 23.8% | ||
| Q3 24 | 92.5% | 14.7% | ||
| Q2 24 | 92.5% | 30.0% |
| Q1 26 | -1.7% | 32.0% | ||
| Q4 25 | 6.1% | -2.2% | ||
| Q3 25 | 12.8% | 31.0% | ||
| Q2 25 | 12.2% | 27.5% | ||
| Q1 25 | 7.9% | 24.2% | ||
| Q4 24 | 59.1% | 18.4% | ||
| Q3 24 | 12.6% | 8.8% | ||
| Q2 24 | 12.6% | 25.3% |
| Q1 26 | 1.4% | 27.7% | ||
| Q4 25 | 96.3% | -7.8% | ||
| Q3 25 | 25.8% | 26.3% | ||
| Q2 25 | 10.1% | 23.0% | ||
| Q1 25 | 7.8% | 19.0% | ||
| Q4 24 | 55.4% | 13.1% | ||
| Q3 24 | 13.1% | 3.0% | ||
| Q2 24 | 13.8% | 19.7% |
| Q1 26 | $0.02 | — | ||
| Q4 25 | $1.61 | $-0.98 | ||
| Q3 25 | $0.42 | $4.08 | ||
| Q2 25 | $0.16 | $3.67 | ||
| Q1 25 | $0.11 | $2.56 | ||
| Q4 24 | $0.86 | $1.73 | ||
| Q3 24 | $0.20 | $0.36 | ||
| Q2 24 | $0.20 | $2.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $128.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | $1.6B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $128.1M | ||
| Q4 25 | $177.7M | $69.2M | ||
| Q3 25 | $258.0M | $156.2M | ||
| Q2 25 | $253.6M | $114.4M | ||
| Q1 25 | $217.7M | $121.8M | ||
| Q4 24 | $319.6M | $90.9M | ||
| Q3 24 | $155.1M | $110.5M | ||
| Q2 24 | $177.1M | $47.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $569.1M | ||
| Q3 25 | — | $569.1M | ||
| Q2 25 | — | $569.2M | ||
| Q1 25 | — | $569.3M | ||
| Q4 24 | — | $568.0M | ||
| Q3 24 | — | $547.7M | ||
| Q2 24 | — | $547.6M |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $917.3M | — | ||
| Q2 25 | $822.4M | — | ||
| Q1 25 | $765.2M | — | ||
| Q4 24 | $732.8M | — | ||
| Q3 24 | $577.2M | — | ||
| Q2 24 | $516.7M | — |
| Q1 26 | $1.6B | $1.0B | ||
| Q4 25 | $1.6B | $969.5M | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.2B | $998.0M | ||
| Q1 25 | $1.1B | $1.0B | ||
| Q4 24 | $1.2B | $1.0B | ||
| Q3 24 | $976.9M | $986.6M | ||
| Q2 24 | $914.1M | $959.4M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
Segment breakdown not available.
UAN
| Fertilizer sales | $166.1M | 92% |
| Other | $14.0M | 8% |
